✦ LIBER ✦

Paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as first line treatment in small cell lung cancer (SCLC): a preliminary analysis of a multicenter randomized phase III trial

✍ Scribed by D. Mavroudis; E. Papadakis; M. Veslemes; M. Agelidou; M. Toubis; A. Agelidou; J. Stavrakakis; S. Papadouris; Ch. Kouroussis; V. Georgoulias

Book ID: 117667939
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 146 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)81400-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter randomized phase III study

A multicenter randomized phase III study comparing paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as front-line treatment in patients with small cell lung cancer (SCLC)

✍ Mavroudis, D; Papadakis, E; Veslemes, M; Agelidou, M; Tsiafaki, X; Agelidou, G; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

40 Prospective randomized trial of high-

40 Prospective randomized trial of high-dose epirubicin-cisplatin (EP) vs etoposide-cisplatin (VP) in small cell lung cancer (SCLC)

✍ González-Larriba, J.L.; Artal, A.; Barneto, I.; Gómez-Codina, J.; Isla, D.; Carr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 144 KB

O-279 A multicenter randomised phase II

O-279 A multicenter randomised phase II study of cisplatin, etoposide, gemcitabine (PEG) versus cisplatin, gemcitabine (PG) as first line treatment in patients with small cell lung cancer (SCLC): Preliminary results

✍ De Marinis, Filippo; Gridelli, Cesare; Lombardo, Marco; Paoluzzi, Luca; Ferraù, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Etoposide-cisplatin (EP) versus four-dru

Etoposide-cisplatin (EP) versus four-drug combination etoposide-cisplatin-epirubicin-cyclophosphamide (PCDE) in extensive disease small cell lung cancer (ED-SCLC). A FNCLCC phase III multicentre study

✍ Pujol, J; Daures, J; Riviere, A; Quoix, E; Depierre, A; Breton, J.L; Lemarie, E; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Randomized trial of high-dose epirubicin

Randomized trial of high-dose epirubicin-cisplatin (HDEP) versus etoposide-cisplatin (EP) in small cell lung cancer (SCLC). Study retrospective in older patients

✍ Camps, C; Artal, A; Gomez-Codina, J; Gonzalez-Larriba, J.L; Barneto, I; Carrato, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Cost-effectiveness analysis of cisplatin

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer

✍ Sumitra THONGPRASERT; Unchalee PERMSUWAN; Chidchanok RUENGORN; Chaiyut CHAROENTU 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB